We additionally demonstrated that the levels of GULP expression were significantly or marginally lower in urothelial neoplasms (vs. non-neoplastic urothelial tissues) and high-grade or muscle-invasive tumors (vs. lower grade or non-muscle-invasive tumors), while we failed to show a strong association between the expression level of GULP1 and the prognosis of the patients who had never received CDDP (prior to tumor recurrence or disease progression). Here, GULP1 is linked to neoplasm.